최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Chirality : the pharmacological, biological, and chemical consequences of molecular asymmetry, v.24 no.12, 2012년, pp.1047 - 1050
Liu, Man (Department of Clinical Pharmacology, Aerospace Center Hospital, Beijing, People's Republic of China) , Zhang, Dan (Department of Clinical Pharmacology, Aerospace Center Hospital, Beijing, People's Republic of China) , Yang, Man (Department of Clinical Pharmacology, Aerospace Center Hospital, Beijing, People's Republic of China) , Zhao, Ting (Department of Clinical Pharmacology, Aerospace Center Hospital, Beijing, People's Republic of China) , Wang, Xiaolin (Department of Clinical Pharmacology, Aerospace Center Hospital, Beijing, People's Republic of China) , Zhang, Yanan (Department of Clinical Pharmacology, Aerospace Center Hospital, Beijing, People's Republic of China) , Han, Jing (Department of Clinical Pharmacology, Aerospace Center Hospital, Beijing, People's Republic of China) , Liu, Huichen (Department of Clinical Pharmacology, Aerospace Center Hospital, Beijing, People's Republic of China)
ABSTRACTThe purpose of this study was to elucidate the pharmacokinetics of terazosin enantiomers in healthy Chinese male subjects. After a single oral dose of 2‐mg terazosin, the plasma concentrations of terazosin enantiomers were measured over the course of 48 h in 12 healthy subjects. The plasma concentrations of (+)‐(R)‐terazosin at all time points were higher than those of (−)‐(S)‐terazosin. The area under the plasma concentration–time curve (AUC0–∞) and maximum plasma concentration of (+)‐(R)‐terazosin were significantly greater than those of the (−)‐(S)‐terazosin (P < 0.01, respectively). The R/S ratio of AUC0–∞ of terazosin was 1.68. For the first time, it was proven that the pharmacokinetics of terazosin was stereoselective in healthy Chinese male subjects. Chirality 24:1047–1050, 2012. © 2012 Wiley Periodicals, Inc.
Forray C , Bard JA , Wetzel JM , Chiu G , Shapiro E , Tang R , Lepor H , Hartig PR , Weinshank RL , Branchek TA . The alpha 1‐adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype . Mol Pharmacol 1994 ; 45 : 703 – 708 .
Nakaki T , Nakayama M , Yamamoto S , Kato R . Alpha 1‐adrenergic stimulation and beta 2‐adrenergic inhibition of DNA synthesis in vascular smooth muscle cells . Mol Pharmacol 1990 ; 37 : 30 – 36 .
Smith P , Rhodes NP , Ke Y , Foster CS . Influence of the alpha1‐adrenergic antagonist, doxazosin, on noradrenaline‐induced modulation of cytoskeletal proteins in cultured hyperplastic prostatic stromal cells . Prostate 1999 ; 38 : 216 – 227 .
Ireland LM , Cain JC , Rotert G , Thomas S , Shoghi S , Hancock AA , Kerwin JF Jr. [3H]R‐terazosin binds selectively to alpha1‐adrenoceptors over alpha2‐adrenoceptors ‐ comparison with racemic [3 H ]terazosin and [3 H ]prazosin . Eur J Pharmacol 1997 ; 327 : 79 – 86 .
Hancock AA , Buckner SA , Ireland LM , Knepper SM , Kerwin JF Jr. Actions of terazosin and its enantiomers at subtypes of alpha 1‐ and alpha 2‐adrenoceptors in vitro . J Recept Signal Transduct Res 1995 ; 15 : 863 – 885 .
Kyncl JJ , Horrom BW . R(+)‐terazosin . Patent No. WO/1992/000073 .
Bu Y , Chen D , Zhao C . Studies on pharmacokinetics and bioequivalence of terazosin hydrochloride tablets . Chin J Pharm Anal 2007 ; 27 : 1361 – 1363 .
Chen J , Lu W , Gao K , Shi Z , Jiang X , Rong Z , Chen H . Studies on the bioequivalence of domestic terazosin tablet in healthy volunteers . Chin Pharm J 2003 ; 38 : 446 – 448 .
Cheah PY , Yuen KH , Liong ML . Improved high‐performance liquid chromatographic analysis of terazosin in human plasma . J Chromatogr B 2000 ; 745 : 439 – 443 .
Sekhar EC , Rao TR , Sekhar KR , Naidu MU , Shobha JC , Rani PU , Kumar TV , Kumar VP . Determination of terazosin in human plasma, using high‐performance liquid chromatography with fluorescence detection . J Chromatogr B 1998 ; 710 : 137 – 142 .
Ferretti R , Gallinella B , La Torre F , Zanitti L , Turchetto L , Mosca A , Cirilli R . Direct high‐performance liquid chromatography enantioseparation of terazosin on an immobilised polysaccharide‐based chiral stationary phase under polar organic and reversed‐phase conditions . J Chromatogr A 2009 ; 1216 : 5385 – 5390 .
Liu M , Zhang D , Han J , Liu H . Enantiomeric separation of terazosin by NP‐HPLC . Chin J Pharm 2012 ; 43 : 53 – 56 .
Zavitsanos AP , Alebic‐Kolbah T . Enantioselective determination of terazosin in human plasma by normal phase high‐performance liquid chromatography–electrospray mass spectrometry . J Chromatogr A 1998 ; 794 : 45 – 56 .
Bansal S , DeStefano A . Key elements of bioanalytical method validation for small molecules . AAPS J 2007 ; 9 : E109 – E114 .
Achari R , Laddu A . Terazosin: a new alpha adrenoceptor blocking drug . J Clin Pharmacol 1992 ; 32 : 520 – 523 .
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.